Merck Director Thulin buys 2,832 shares for $249,999.98, raising holdings from 100 to 2,932 shares.
Inge G. Thulin, a Director at Merck & Co., Inc., purchased 2,832 shares at $88.25 on 2025-02-06, increasing his holdings by approximately 2832.9% from a very small base of 100 shares. The transaction occurred at a price roughly 1.1% above the current price of $87.28, though the stock is currently -34.4% from its 52-week high of $132.96 and down -12.6% over the past 30 days. This represents a substantial increase in personal equity stake in the company, though the absolute dollar amount of $249,999.98 remains modest relative to Merck's $220.8B market capitalization and quarterly net income of $3.2B. The purchase follows a period of stock weakness, providing a data point on insider appetite at current valuation levels.